Matt Curran

Matt Curran, CFA, CAIA, has extensive experience in investment research and analytics, currently serving as Executive Vice President and Research Consultant at Meketa Investment Group since November 2017, with a progressive career spanning roles from Associate to Senior Vice President. Prior to Meketa Investment Group, Matt was a Scientific Associate II at Novartis Institutes for BioMedical Research from March 2014 to November 2017 and gained early research experience at Boston Children's Hospital, Harvard Stem Cell Institute, and Salk Institute for Biological Studies. Matt holds a Bachelor of Arts degree in Biology from the College of the Holy Cross and completed medical education at UMass Chan Medical School between 2010 and 2013.